Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamin K 2”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Not applicableLooking for participantsNCT05943457
What this trial is testing

Vitamin K2 Supplementation in Adult Episodic Migraine

Who this might be right for
Migraine HeadacheArterial StiffnessVitamin K Deficiency
Sola Aoun Bahous, M.D. Ph.D. 160
Not applicableStudy completedNCT03243890
What this trial is testing

The Aortic Valve DECalcification (AVADEC) Trial

Who this might be right for
Aortic Valve StenosisMultidetector Computed TomographyVitamin K 2+1 more
Axel Diederichsen 389
Not applicableStudy completedNCT05081960
What this trial is testing

Evaluating the Vitamin K2 Status of Calcium-based Stone Formers

Who this might be right for
Kidney CalculiCalcium Oxalate Kidney StonesVitamin K 2+5 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Not applicableStudy completedNCT03015025
What this trial is testing

Pharmacogenetic Dosage Algorithm for Acenocoumarol

Who this might be right for
Atrial FibrillationVenous ThrombosesCardiac Valve Disease
Instituto de Investigación Hospital Universitario La Paz 340
Not applicableStudy completedNCT04382027
What this trial is testing

Pharmacokinetics of Omega-3 Monoglycerides

Who this might be right for
Healthy
Université de Sherbrooke 20
Not applicableStudy completedNCT04285450
What this trial is testing

The Clinical Effect of Vitamin K Administration in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Cairo University 106
Post-approval studies (Phase 4)Study completedNCT02415400
What this trial is testing

Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Who this might be right for
Acute Coronary Syndromes
Bristol-Myers Squibb 4,614
Large-scale testing (Phase 3)Study completedNCT01006733
What this trial is testing

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT

Who this might be right for
Thromboembolism
Washington University School of Medicine 1,598
Not applicableStudy completedNCT00642551
What this trial is testing

Beneficial Effects of Long Term Menaquinone-7

Who this might be right for
Bone LossArteriosclerosis
Maastricht University Medical Center 240
Not applicableUnknownNCT02366481
What this trial is testing

Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes (Vita-K 'n' Adults Study)

Who this might be right for
ObesityInsulin ResistanceInsulin Sensitivity+2 more
Augusta University 30
Testing effectiveness (Phase 2)Study completedNCT04218266
What this trial is testing

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

Who this might be right for
Atrial Fibrillation (AF)
Bayer 755
Not applicableStudy completedNCT02392767
What this trial is testing

Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function

Who this might be right for
Endothelial DysfunctionHyperhomocysteinemiaHypertension Grade I, Subgroup "Borderline" (WHO)
Dr. Loges & Co. GmbH 25
Not applicableUnknownNCT00970892
What this trial is testing

VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

Who this might be right for
Atrial FibrillationCardiac ThrombusDeep Vein Thrombosis+4 more
Ankara University 500
Testing effectiveness (Phase 2)Study completedNCT05205863
What this trial is testing

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

Who this might be right for
Healthy Volunteers
Prothya Biosolutions 69
Post-approval studies (Phase 4)Study completedNCT03799822
What this trial is testing

Oral Anticoagulation in Hemodialysis

Who this might be right for
Atrial Fibrillation
Onze Lieve Vrouw Hospital 132
Not applicableStudy completedNCT04189796
What this trial is testing

Jarlsberg Cheese Compared to Camembert Cheese

Who this might be right for
Healthy WomenOsteocalcin
Prof Stig Larsen 64
Not applicableActive Not RecruitingNCT06817512
What this trial is testing

Ischemic Stroke Nutrition Intervention Study

Who this might be right for
Ischemic Stroke
Harbin Medical University 190
Post-approval studies (Phase 4)Looking for participantsNCT06707909
What this trial is testing

The Local Effect of Vitamin K2 on Bone Remodeling in Socket Preservation

Who this might be right for
Socket Preservation
Cairo University 20
Large-scale testing (Phase 3)Study completedNCT04477811
What this trial is testing

Comparative Study Evaluating the Effect of Vitamin K1 Versus Vitamin K2 on Vascular Calcification in Dialysis Patients

Who this might be right for
End Stage Renal Disease on Dialysis
Ain Shams University 40
Testing effectiveness (Phase 2)Study completedNCT00252005
What this trial is testing

Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study

Who this might be right for
Deep-Vein Thrombosis
Bristol-Myers Squibb 520
Next Page